Skip to content
Dose Brief
Menu
No. 145 here · Grade C

NEUVÉ Health review

NEUVE Health prices compounded semaglutide from $179 a month and tirzepatide from $240, all of it microdosing, and three of its own pages disagree on whether the medication is in that figure.

Visit NEUVÉ Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $179/mo (microdose tier, compounded)
Tirzepatide
From $240/mo (microdose tier, compounded)
Coverage
All 50 states claimed; members in 40+
Brand-name
Compounded only

Prices read from NEUVÉ Health's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 September 2026, and read on the provider's own site rather than taken on trust: we checked https://neuvemd.com/ on 2026-09-01 and this row reflects what that page says. The line we publish is From $179/mo (microdose tier, compounded). There is no earlier reading of ours to compare it against yet.

The scorecard

NEUVÉ Health scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability70/100
Transparency88/100
Access Breadth96/100
Clinical Oversight69/100
Track Record64/100

What we like

  • The full ladder is public before any intake, twelve products with no prepay tiers and no struck-through anchors.
  • A daily sublingual option is priced alongside the weekly injection for both molecules.
  • The pharmacy class is now stated as 503A and 503B certified compounding pharmacies.
  • The laboratories are named, Quest and LabCorp, which few in this category do.
  • The legal entity is published, along with the state whose law governs it.

The caveats

  • Three pages disagree on whether the drug is in the price: one is headed all-in monthly pricing while its own fine print and the financial policy bill medication separately through an unnamed clinical partner.
  • The homepage claims all 50 states and, three times on the same page, members in 40-plus.
  • No compounding pharmacy is named, only the classes it belongs to.
  • No physician is named and no NPI number appears; the only named person is a non-physician founder.
  • Every legal page says it is still being reviewed by counsel and may change before public launch.

The brief

Best for: Shoppers who specifically want a microdose protocol and will ask what the monthly fee actually covers. NEUVE Health prices compounded semaglutide from $179 a month and tirzepatide from $240, all of it microdosing, and three of its own pages disagree on whether the medication is in that figure.

Ranked #145 of 536 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about NEUVÉ Health.

Closest here

The providers scoring nearest NEUVÉ Health — the realistic shortlist if you're weighing it.

Weighing NEUVÉ Health against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs NEUVÉ Health, and every provider that outranks it is listed on the NEUVÉ Health alternatives ranking.

More providers we track (24)

505 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect NEUVÉ Health's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on NEUVÉ Health's site. Not medical advice; see our disclosure.

← Back to all rankings